Lindsey M Duca1, David M Maahs1, Irene E Schauer1, Bryan C Bergman1, Kristen J Nadeau1, Petter Bjornstad1, Marian Rewers1, Janet K Snell-Bergeon1. 1. Barbara Davis Center for Diabetes (L.M.D., D.M.M., P.B., M.R., J.K.S.-B.), School of Medicine, University of Colorado, Aurora, Colorado 80045; Colorado School of Public Health (L.M.D., D.M.M., J.K.S.-B.), University of Colorado, Aurora, Colorado 80045; Division of Endocrinology, Metabolism, and Diabetes (I.E.S., B.C.B.), Department of Medicine, School of Medicine, University of Colorado, Aurora, Colorado 80045; Division of Pediatric Endocrinology (K.J.N.), Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado 80045; and Denver VA Medical Center (I.E.S.), Denver, Colorado 80220.
Abstract
CONTEXT: People with type 1 diabetes (T1D) have markedly reduced insulin sensitivity (IS) compared to their nondiabetic counterparts, and reduced IS is linked to higher cardiovascular risk. OBJECTIVE: This study aimed to develop and validate an improved method for estimating IS in people with T1D. DESIGN: Prospective cohort. SETTING: Adults (36 with T1D, 41 nondiabetic) were recruited from the Coronary Artery Calcification in Type 1 Diabetes (CACTI) study for measurement of IS by hyperinsulinemic-euglycemic clamp to develop a clinically useful IS prediction equation (eIS) for T1D and nondiabetic individuals. These equations were then compared with previously published equations from the SEARCH and Pittsburgh Epidemiology of Diabetes Complications studies for the ability to predict measured IS in test sets of adults and adolescents from independent clamp studies. INTERVENTION: None. MAIN OUTCOME MEASURE: Comparison of clamp-measured IS to estimated IS. RESULTS: The best-fit prediction model (eIS) differed by diabetes status and included waist circumference, triglycerides, adiponectin, and diastolic blood pressure in all CACTI adults and insulin dose in adults with T1D (adjusted R(2) = 0.64) or fasting glucose and hemoglobin A1c (HbA1c) in nondiabetic adults (adjusted R(2) = 0.63). The eIS highly correlated with clamp-measured IS in all of the non-CACTI comparison populations (r = 0.83, P = .0002 in T1D adults; r = 0.71, P = .01 in nondiabetic adults; r = 0.44, P = .008 in T1D adolescents; r = 0.44, P = .006 in nondiabetic adolescents). CONCLUSIONS: eIS performed better than previous equations for estimating IS in individuals with and without T1D. These equations could simplify point-of-care assessment of IS to identify patients who could benefit from targeted intervention.
CONTEXT: People with type 1 diabetes (T1D) have markedly reduced insulin sensitivity (IS) compared to their nondiabetic counterparts, and reduced IS is linked to higher cardiovascular risk. OBJECTIVE: This study aimed to develop and validate an improved method for estimating IS in people with T1D. DESIGN: Prospective cohort. SETTING: Adults (36 with T1D, 41 nondiabetic) were recruited from the Coronary Artery Calcification in Type 1 Diabetes (CACTI) study for measurement of IS by hyperinsulinemic-euglycemic clamp to develop a clinically useful IS prediction equation (eIS) for T1D and nondiabetic individuals. These equations were then compared with previously published equations from the SEARCH and Pittsburgh Epidemiology of Diabetes Complications studies for the ability to predict measured IS in test sets of adults and adolescents from independent clamp studies. INTERVENTION: None. MAIN OUTCOME MEASURE: Comparison of clamp-measured IS to estimated IS. RESULTS: The best-fit prediction model (eIS) differed by diabetes status and included waist circumference, triglycerides, adiponectin, and diastolic blood pressure in all CACTI adults and insulin dose in adults with T1D (adjusted R(2) = 0.64) or fasting glucose and hemoglobin A1c (HbA1c) in nondiabetic adults (adjusted R(2) = 0.63). The eIS highly correlated with clamp-measured IS in all of the non-CACTI comparison populations (r = 0.83, P = .0002 in T1D adults; r = 0.71, P = .01 in nondiabetic adults; r = 0.44, P = .008 in T1D adolescents; r = 0.44, P = .006 in nondiabetic adolescents). CONCLUSIONS: eIS performed better than previous equations for estimating IS in individuals with and without T1D. These equations could simplify point-of-care assessment of IS to identify patients who could benefit from targeted intervention.
Authors: Valéria Lamounier-Zepter; Monika Ehrhart-Bornstein; Stefan R Bornstein Journal: Best Pract Res Clin Endocrinol Metab Date: 2006-09 Impact factor: 4.690
Authors: D Dabelea; R B D'Agostino; C C Mason; N West; R F Hamman; E J Mayer-Davis; D Maahs; G Klingensmith; W C Knowler; K Nadeau Journal: Diabetologia Date: 2010-10-01 Impact factor: 10.122
Authors: D M Maahs; K Nadeau; J K Snell-Bergeon; I Schauer; B Bergman; N A West; M Rewers; S R Daniels; L G Ogden; R F Hamman; D Dabelea Journal: Diabet Med Date: 2011-02 Impact factor: 4.359
Authors: Aaron K F Wong; Ruth Symon; Matlooba A AlZadjali; Donald S C Ang; Simon Ogston; AnnaMaria Choy; John R Petrie; Allan D Struthers; Chim C Lang Journal: Eur J Heart Fail Date: 2012-06-27 Impact factor: 15.534
Authors: Kimberly A Driscoll; Karen D Corbin; David M Maahs; Richard Pratley; Franziska K Bishop; Anna Kahkoska; Korey K Hood; Elizabeth Mayer-Davis Journal: Curr Diab Rep Date: 2017-08 Impact factor: 4.810
Authors: Stephanie Cung; Laura Pyle; Kristin Nadeau; Dana Dabelea; Melanie Cree-Green; Shanlee M Davis Journal: J Investig Med Date: 2021-09-07 Impact factor: 2.895
Authors: Petter Bjornstad; David M Maahs; Lindsey M Duca; Laura Pyle; Marian Rewers; Richard J Johnson; Janet K Snell-Bergeon Journal: J Diabetes Complications Date: 2016-02-11 Impact factor: 2.852
Authors: Teresa Buckner; Baohai Shao; Robert H Eckel; Jay W Heinecke; Karin E Bornfeldt; Janet Snell-Bergeon Journal: J Clin Lipidol Date: 2020-10-31 Impact factor: 5.365